SCHEMBL7929244

SCHEMBL7929244

CC1=C(C#N)S(=O)(=O)c2c(F)cc(C(F)(F)F)cc2N1

nearest known ligand 0.32

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.32
MAPT P10636 1/20 0.32
HPGD P15428 1/20 0.32
ALOX15 P16050 1/20 0.32
HSD17B10 Q99714 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7690177 0.68 ALDH1A1 (0.36) ALDH1A1MAPTHPGDALOX15HSD17B10
SCHEMBL4256305 0.67 CA12 (0.44) ALDH1A1MAPT
SCHEMBL4264227 0.67 CA1 (0.35)
SCHEMBL7922717 0.64 AR (0.32) MAPT
SCHEMBL15958871 0.62 TRPV4 (0.42) ALDH1A1MAPTHPGDALOX15HSD17B10
SCHEMBL4257927 0.61 ABCC8 (0.49) ALDH1A1MAPTHPGDHSD17B10
SCHEMBL27614015 0.60 CYP11B1 (0.40)
SCHEMBL7932691 0.60
SCHEMBL28994625 0.60 TRPV4 (0.54) ALDH1A1MAPTHPGD
SCHEMBL16327958 0.57 PDE2A (0.41) ALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6232310-B1 ANTIDIABETIC AGENTS NOVO NORDISK A/S (DK) 2001-05-15 US claimed
US-6232310-B1 ANTIDIABETIC AGENTS NOVO NORDISK A/S (DK) 2001-05-15 US disclosed